Transfusion

Cover image for Transfusion

June 2001

Volume 41, Issue 6

Pages 723–851

  1. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. The human blood platelet, resting and active (page 723)

      John Hartwig

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060723.x

  2. EDITORIAL

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. The use of platelet concentrates versus plateletpheresis—the donor perspective (pages 727–729)

      Ritchard G. Cable and Richard L. Edwards

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060727.x

  3. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Incidence rates of viral infections among repeat donors:are frequent donors safer? (pages 730–735)

      George B. Schreiber, Simone A. Glynn, Michael P. Busch, Usha K. Sharma, David J. Wright, Steven H. Kleinman and for the Retrovirus Epidemiology Donor Study

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060730.x

    2. Repeat whole-blood and plateletpheresis donors:unreported deferrable risks, reactive screening tests, andresponse to incentive programs (pages 736–743)

      Simone A. Glynn, James W. Smith, George B. Schreiber, Steven H. Kleinman, Catharie C. Nass, James Bethel, Bipasa Biswas, Ruth A. Thomson, Alan E. Williams and for the Retrovirus Epidemiology Donor Study

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060736.x

    3. Absence of risk factors for false-positive test results inblood donors with a reactive test result inan automated treponemal test (PK-TP) for syphilis (pages 744–750)

      Sharyn L. Orton, Roger Y. Dodd, Alan E. Williams and for the ARCNET Epidemiology Group

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060744.x

    4. Seroprevalence of known and putative hepatitis markers inUnited States blood donors with ALT levels at least 120 IU per L (pages 751–755)

      Edward P. Notari IV, Sharyn L. Orton, Ritchard G. Cable, Alfred J. Grindon, Bruce A. Lenes, Alan E. Williams, Kimberly M. McMillan, Jonathan J. Trouern-Trend, Jennifer S. Wolf-Nugent, Yi-Ling Xu, Roger Y. Dodd and for the ARCNET Program

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060751.x

    5. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations (pages 756–761)

      Ellen F. Lazarus, Janet Browning, James Norman, Jaime Oblitas and Susan F. Leitman

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060756.x

  4. IMMUNOHEMATOLOGY

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support (pages 762–765)

      Cristina Sanz, Carolina Freire, Inaki Alcorta, Antonio Ordinas and Arturo Pereira

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060762.x

    2. Platelet alloantibodies in transfused patients (pages 766–770)

      Volker Kiefel, Claudia König, Hartmut Kroll and Sentot Santoso

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060766.x

    3. The expression of NA antigens in people withunusual Fcγ receptor III genotypes (pages 775–782)

      Kazuhiko Matsuo, Jo L. Procter, Stephen Chanock and David F. Stroncek

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060775.x

  5. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Immune reconstitution after autologous selectedperipheral blood progenitor cell transplantation:comparison of two CD34+ cell-selection systems (pages 783–789)

      Luca Laurenti, Federica Sorà, Nicola Piccirillo, Patrizia Chiusolo, Silvia Cicconi, Sergio Rutella, Riccardo Serafini, Maria Grazia Garzia, Giuseppe Leone and Simona Sica

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060783.x

  6. TRANSFUSION PRACTICE

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery (pages 790–793)

      Neil Blumberg, Joanna M. Heal, George L. Hicks Jr. and William H. Risher

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060790.x

    2. Number of RBC units and rate of transfusionto anemic HIV-positive patients assigned to receiveWBC-reduced or non-WBC-reduced RBCs: the Viral Activation Transfusion Study experience (pages 794–798)

      Mark E. Brecher, Darrell J. Triulzi, Susan F. Assmann and for the Viral Activation Transfusion Study

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060794.x

    3. Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions (pages 803–808)

      Antonio Del Vecchio, Martha C. Sola, Douglas W. Theriaque, Alan D. Hutson, K.J. Kao, Dale Wright, Maria G. Garcia, Brad H. Pollock and Robert D. Christensen

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060803.x

  7. BLOOD COMPONENTS

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. The effect of the interruption of agitation on plateletquality during storage for transfusion (pages 809–814)

      Suzanne Hunter, Janice Nixon and Scott Murphy

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060809.x

  8. TRANSFUSION MEDICINE

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. MCV as a guide to phlebotomy therapyfor hemochromatosis (pages 819–827)

      Charles D. Bolan, Cathy Conry-Cantilena, Glorice Mason, Tracey A. Rouault and Susan F. Leitman

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060819.x

    2. HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia (pages 828–831)

      Seppo Parkkila, Onni Niemelä, Eeva-Riitta Savolainen and Pirjo Koistinen

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060828.x

  9. HEALTH POLICY

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Health and economic consequences of HCV lookback (pages 832–839)

      Arturo Pereira

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060832.x

  10. COMMITTEE REPORT

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Cryoprecipitate-reduced plasma:rationale for use and efficacy in the treatment ofthrombotic thrombocytopenic purpura (pages 840–844)

      Douglas P. Blackall, Lynne Uhl, Steven L. Spitalnik and for the Transfusion Practices Committee

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060840.x

  11. LETTERS TO THE EDITOR

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. Reply (pages 846–847)

      Tobias J. Legler, Joachim Riggert and K.-H. Heermann

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060846.x

    2. The first case of HCV seroconversion in Portugal after the introduction of HCV NAT screening (page 848)

      Fernando M. Araújo, Isabel Henriques, Fátima Monteiro, Elsa Meireles, Maria C. Koch, Regina Celeste and L.M. Cunha-Ribeiro

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060848.x

  12. BOOK REVIEW

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
  13. ERRATUM

    1. Top of page
    2. TRANSFUSION MEDICINE ILLUSTRATED
    3. EDITORIAL
    4. BLOOD DONORS AND BLOOD COLLECTION
    5. IMMUNOHEMATOLOGY
    6. TRANSPLANTATION AND CELLULAR ENGINEERING
    7. TRANSFUSION PRACTICE
    8. BLOOD COMPONENTS
    9. TRANSFUSION MEDICINE
    10. HEALTH POLICY
    11. COMMITTEE REPORT
    12. LETTERS TO THE EDITOR
    13. BOOK REVIEW
    14. ERRATUM
    1. TRANSFUSION 2001;41:470-476. (page 851)

      Version of Record online: 21 APR 2002 | DOI: 10.1046/j.1537-2995.2001.41060851.x

SEARCH

SEARCH BY CITATION